156 related articles for article (PubMed ID: 33099483)
21. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression profiling of Xp11 renal cell carcinoma.
Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
[TBL] [Abstract][Full Text] [Related]
23. GSTM1 genotype is an independent prognostic factor in clear cell renal cell carcinoma.
Coric VM; Simic TP; Pekmezovic TD; Basta-Jovanovic GM; Savic-Radojevic AR; Radojevic-Skodric SM; Matic MG; Suvakov SR; Dragicevic DP; Radic TM; Dzamic ZM; Pljesa-Ercegovac MS
Urol Oncol; 2017 Jun; 35(6):409-417. PubMed ID: 28284893
[TBL] [Abstract][Full Text] [Related]
24. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
25. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.
Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W
Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583
[TBL] [Abstract][Full Text] [Related]
26. Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis.
Benna C; Rajendran S; Spiro G; Tropea S; Del Fiore P; Rossi CR; Mocellin S
J Transl Med; 2018 Dec; 16(1):338. PubMed ID: 30518396
[TBL] [Abstract][Full Text] [Related]
27. Plasma Circulating Tumor DNA and Clonal Hematopoiesis in Metastatic Renal Cell Carcinoma.
Bacon JVW; Annala M; Soleimani M; Lavoie JM; So A; Gleave ME; Fazli L; Wang G; Chi KN; Kollmannsberger CK; Wyatt AW; Nappi L
Clin Genitourin Cancer; 2020 Aug; 18(4):322-331.e2. PubMed ID: 32046920
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in genes of the renin-angiotensin-aldosterone system and renal cell cancer risk: interplay with hypertension and intakes of sodium, potassium and fluid.
Deckers IA; van den Brandt PA; van Engeland M; van Schooten FJ; Godschalk RW; Keszei AP; Schouten LJ
Int J Cancer; 2015 Mar; 136(5):1104-16. PubMed ID: 24978482
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma.
Xing Q; Li R; Xu A; Qin Z; Tang J; Zhang L; Tang M; Han P; Wang W; Qin C; Du M; Zhang W
Cancer Med; 2019 Jun; 8(6):2886-2896. PubMed ID: 31038847
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients.
Dornbusch J; Walter M; Gottschalk A; Obaje A; Junker K; Ohlmann CH; Meinhardt M; Zacharis A; Zastrow S; Schoffer O; Grimm MO; Klug SJ; Wirth MP; Fuessel S
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1171-82. PubMed ID: 26935927
[TBL] [Abstract][Full Text] [Related]
31. microRNA‑572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis.
Pan X; Li Z; Zhao L; Quan J; Zhou L; Xu J; Xu W; Guan X; Li H; Yang S; Gui Y; Lai Y
Oncol Rep; 2018 Nov; 40(5):3092-3101. PubMed ID: 30132566
[TBL] [Abstract][Full Text] [Related]
32.
Chang CF; Huang SP; Hsueh YM; Chen PL; Lee CH; Geng JH; Huang CY; Bao BY
Cancer Genomics Proteomics; 2023; 20(5):469-475. PubMed ID: 37643785
[TBL] [Abstract][Full Text] [Related]
33. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
[TBL] [Abstract][Full Text] [Related]
34. HNF‑4α downregulation promotes tumor migration and invasion by regulating E‑cadherin in renal cell carcinoma.
Gao Y; Yan Y; Guo J; Zhang Q; Bi D; Wang F; Chang Z; Lu L; Yao X; Wei Q
Oncol Rep; 2019 Sep; 42(3):1066-1074. PubMed ID: 31322246
[TBL] [Abstract][Full Text] [Related]
35. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
36. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
37. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
39. Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.
Wang ZL; Zhang P; Li HC; Yang XJ; Zhang YP; Li ZL; Xue L; Xue YQ; Li HL; Chen Q; Chong T
Cancer Biol Ther; 2019; 20(4):505-512. PubMed ID: 30359544
[TBL] [Abstract][Full Text] [Related]
40. Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.
Teixeira AL; Dias F; Ferreira M; Gomes M; Santos JI; Lobo F; Maurício J; Machado JC; Medeiros R
PLoS One; 2014; 10(4):e0103258. PubMed ID: 25909813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
